MATH vs GANX Comparison

Metalpha Technology Holding Ltd is to enable the transition towards digital asset technology. The company aims to provide a crypto derivatives product services for users world-wide. The company has three operating segments. The Longyun operating segment reflects the Company's crowdfunding and incubation business. The Dacheng Liantong operating segment reflects the Company's business of platform services. The Metalpha operating segment reflects the Company's business of proprietary trading of digital assets. The Company is generates its revenue from Hong Kong.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.